Comment on ‘Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy’ – (Eye 28, 1525 (December 2014))

11 December 2014

This news item is available to RCOphth members only, please log in below to access.